Actively Recruiting
Study of 3D Ultrasonography to Check Surgical Margins After Removal of Skin Squamous Cell Carcinoma
Led by Rigshospitalet, Denmark · Updated on 2026-02-11
30
Participants Needed
1
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new imaging method called ex vivo 3D ultrasonography to assess surgical margins in patients aged 18 years and older who are undergoing surgery for primary cutaneous squamous cell carcinoma. The study aims to compare this ultrasound technique with traditional histopathology to determine how accurately it measures the deep margin distance of tumors after surgical removal. Participants will have their surgical specimens scanned with a 3D ultrasonography device connected to a high-frequency ultrasound machine shortly after surgery. A trained investigator, unaware of the pathology results, will interpret these scans. The specimens will then undergo standard histopathological examination by a pathologist blinded to the ultrasound findings. A third researcher will match the images from both methods to compare measurements. During the study, patients will be monitored within 10 to 14 days after enrollment to measure the deep margin distance, tumor depth of invasion, and tumor size in three dimensions using both ultrasound and histopathology. The study involves standard surgical treatment followed by detailed imaging and tissue analysis to assess the accuracy of the ultrasound method. The total follow-up time for these measurements is within two weeks from surgery.
CONDITIONS
Brief Title
Ex Vivo Cutaneous SCC
Research Team
L
Linnea Langhans, MD, PhD
M
Martin Garset-Zamani, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here